Eye scanner firm Optos reveals drop in headline revenues

Optos, the medical retinal imaging company, unveiled Tuesday a four per cent dip in headline revenues amid a tough European economy.

Optos, the medical retinal imaging company, unveiled Tuesday a four per cent dip in headline revenues amid a tough European economy.

The eye scanner firm reported $40.3m in headline revenues for the three months to December 31st, compared to $41.9m the previous year, driven by a drop in finance and operating leases as more customers opted to buy devices outright.

However, Optos had a strong underlying revenue growth of 18% compared to the year earlier, buoyed by a large volume of capital sales.

The group won 274 new customers during the first quarter of the year which it said was traditionally its weakest period. Optos sold 267 of its Daytona devices during the period to new and existing customers.

The company also rented out 250 Daytona devices to a major corporation for a year.

Chief Executive Officer, Roy Davis, said he was encouraged by the results given the strain of the economy.

"Our underlying revenue growth for (the first quarter) was positive, against a robust comparable period," he said.

"Whilst continuing economic difficulties in Europe have adversely affected trading conditions in this relatively modest market for Optos, trading elsewhere was strong in December and continues to be so in the first weeks of the second quarter."

Shares fell 3.95% to 188.25p at 9:30 Tuesday.

RD

Recommended

The MoneyWeek Podcast: picking stocks is fun, but you need to do your homework
Investment strategy

The MoneyWeek Podcast: picking stocks is fun, but you need to do your homework

John Stepek talks to Steve Clapham, investor, analyst and author of The Smart Money Method, about the dangers in picking individual stocks and why you…
8 Apr 2021
BP looks set to return more money to shareholders as it beats expectations
Energy stocks

BP looks set to return more money to shareholders as it beats expectations

Oil major BP is to embark on a share buyback programme after significantly reducing its debts. Saloni Sardana looks at what it means for your portfoli…
6 Apr 2021
Deliveroo has hit the market – but it’s not getting the warmest welcome
UK stockmarkets

Deliveroo has hit the market – but it’s not getting the warmest welcome

Food delivery company Deliveroo made its debut on the stockmarket this morning. But with the share price sliding by 30% straight away, it’s not made t…
31 Mar 2021
Three stocks to buy now that will come back stronger after Covid-19
Share tips

Three stocks to buy now that will come back stronger after Covid-19

Professional investor Ed Wielechowski of Odyssean Capital, chooses three compelling stocks that should thrive in a post-pandemic world.
29 Mar 2021

Most Popular

“Joke” cryptocurrency dogecoin goes to the moon. What’s going on?
Bitcoin

“Joke” cryptocurrency dogecoin goes to the moon. What’s going on?

Dogecoin – a cryptocurrency created as a joke – has risen by more than 9,000% this year alone. Saloni Sardana looks at how something that began as an …
19 Apr 2021
Lab-grown meat: how “moo’s law” will drive innovation
Soft commodities

Lab-grown meat: how “moo’s law” will drive innovation

Jim Mellon and Anthony Chow, co-founders of Aim-listed Agronomics, explain why they believe that “cellular agriculture” will benefit from massive long…
16 Apr 2021
The bitcoin bubble will burst: here’s how to play it
Bitcoin

The bitcoin bubble will burst: here’s how to play it

The cryptocurrency’s price has soared far beyond its fundamentals, says Matthew Partridge. Here, he looks at how to short bitcoin.
12 Apr 2021